Abbott Laboratories (ABT)
NYSE: ABT · IEX Real-Time Price · USD
106.29
+0.32 (0.30%)
At close: May 1, 2024, 4:00 PM
106.24
-0.05 (-0.05%)
After-hours: May 1, 2024, 7:16 PM EDT
Abbott Laboratories Revenue
In the year 2023, Abbott Laboratories had annual revenue of $40.11B, a decrease of -8.12%. Revenue in the quarter ending December 31, 2023 was $10.24B with 1.49% year-over-year growth.
Revenue (ttm)
$40.11B
Revenue Growth
-8.12%
P/S Ratio
4.60
Revenue / Employee
$351,833
Employees
114,000
Market Cap
184.43B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 40.11B | -3.54B | -8.12% |
Dec 31, 2022 | 43.65B | 578.00M | 1.34% |
Dec 31, 2021 | 43.08B | 8.47B | 24.47% |
Dec 31, 2020 | 34.61B | 2.70B | 8.48% |
Dec 31, 2019 | 31.90B | 1.33B | 4.34% |
Dec 31, 2018 | 30.58B | 3.19B | 11.64% |
Dec 31, 2017 | 27.39B | 6.54B | 31.35% |
Dec 31, 2016 | 20.85B | 448.00M | 2.20% |
Dec 31, 2015 | 20.41B | 158.00M | 0.78% |
Dec 31, 2014 | 20.25B | 590.00M | 3.00% |
Dec 31, 2013 | 19.66B | 607.00M | 3.19% |
Dec 31, 2012 | 19.05B | -2.36B | -11.01% |
Dec 31, 2011 | 21.41B | -13.76B | -39.13% |
Dec 31, 2010 | 35.17B | 4.40B | 14.31% |
Dec 31, 2009 | 30.76B | 1.24B | 4.19% |
Dec 31, 2008 | 29.53B | 3.61B | 13.94% |
Dec 31, 2007 | 25.91B | 3.44B | 15.30% |
Dec 31, 2006 | 22.48B | 138.51M | 0.62% |
Dec 31, 2005 | 22.34B | 2.66B | 13.51% |
Dec 31, 2004 | 19.68B | 2.40B | 13.89% |
Dec 31, 2003 | 17.28B | 2.00B | 13.09% |
Dec 31, 2002 | 15.28B | -1.01B | -6.18% |
Dec 31, 2001 | 16.29B | 2.54B | 18.47% |
Dec 31, 2000 | 13.75B | 568.29M | 4.31% |
Dec 31, 1999 | 13.18B | 664.89M | 5.31% |
Dec 31, 1998 | 12.51B | 623.45M | 5.24% |
Dec 31, 1997 | 11.89B | 875.82M | 7.95% |
Dec 31, 1996 | 11.01B | 1.00B | 10.00% |
Dec 31, 1995 | 10.01B | 856.19M | 9.35% |
Dec 31, 1994 | 9.16B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck & Co. | 60.12B |
Pfizer | 58.50B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Amgen | 28.19B |
Danaher | 22.52B |
ABT News
- 12 hours ago - 24 Dividend Aristocrats in the stock market with the fastest-growing payouts - Market Watch
- 2 days ago - Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee - PRNewsWire
- 9 days ago - Should You Pick Abbott Stock At $105 After An Upbeat Q1? - Forbes
- 14 days ago - Abbott Labs Stock Falls as Q2 Guidance Outweighs Earnings Beat - Investopedia
- 14 days ago - Abbott beats estimates, reports a 2.2% rise in Q1 sales - Invezz
- 14 days ago - Abbott Labs Stock Is Slipping. Disappointing Guidance Trumps a Strong Quarter. - Barrons
- 14 days ago - Abbott Labs first-quarter results top estimates amid strong medical device sales - Market Watch
- 14 days ago - Abbott beats quarterly profit estimates on strong medical device sales - Reuters